Elucid Software Quantifies Plaque Morphology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers
Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment Effects
Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the EVAPORATE (Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy, ClinicalTrials.gov Identifier: NCT02926027) study at the live session Late-Breaking Science: be the first to know!
for ESC Preventive Cardiology 2021. The presentation, entitled ....

United States , Kostenloser Wertpapierhandel , Craig Granowitz , Sam Choinski , Andrew Buckler , Shik Communications , Amarin Corp , Elucid Software Quantifies Plaque Morphology , Enable Better Assessment , Improving Coronary Atherosclerosis , Breaking Science , Icosapent Ethyl , Coronary Plaque Morphology , Chief Medical Officer , Late Breaking Science , Lipid Rich Necrotic Core , ஒன்றுபட்டது மாநிலங்களில் , ஆண்ட்ரூ பக்லர் , அமரின் கார்ப் , உடைத்தல் அறிவியல் , தலைமை மருத்துவ அதிகாரி , தாமதமாக உடைத்தல் அறிவியல் ,